Analyst Color

NetApp Inc. (NASDAQ: NTAP) reported a first-quarter earnings beat Wednesday, and second-quarter guidance fell relatively in-line with consensus estimates. Wall Street Weighs In Deutsche Bank analyst Sherri Scribner maintained a Sell rating on NetApp and raised the price...

NVIDIA Corporation (NASDAQ: NVDA) reported fiscal-year second-quarter results that were slightly ahead of estimates. The company's third-quarter revenue guidance was below expectations. The Analyst Morgan Stanley analyst Joseph Moore maintained his Overweight rating and $273 price target for...

Tax software maker Avalara Inc (NYSE: AVLR) made an initial public offering of 7.5 million shares at $24 each, with the shares priced on June 15. The Analyst Goldman Sachs analyst Jesse Hulsing upgraded Avalara from Neutral to Buy and maintained a 12-month price target of $45, suggesting 30-...

Kimberly Clark Corp (NYSE: KMB)'s announcement that it's raising prices on a host of key items in North America triggered a sell-side upgrade Thursday.  The Analyst  JPMorgan analyst Andrea Teixeira upgraded Kimberly Clark from Underweight to Neutral and raised the price...

Uxin Ltd (ADR) (NASDAQ: UXIN), a Chinese e-commerce platform for used cars, won over a sell-side bull Thursday, with Goldman Sachs identifying three key strengths in the company. The Analyst Analyst Ronald Keung initiated coverage of Uxin shares with a Buy rating and 12-month price target...

Tesla Inc (NASDAQ: TSLA) has been the talk of the town on Wall Street in recent weeks, and analysts are weighing in on Tesla and CEO Elon Musk’s controversial proposal to take the company private on a seemingly daily basis. Impressive Production Evercore ISI analyst George Galliers visited...

A near-term recovery for Coty Inc (NYSE: COTY) seems unlikely, according to a new analyst report. The Analyst Bank of America analyst Olivia Tong downgraded Coty from Buy to Underperform and lowered her price target from $16 to $10. The Thesis Bank of America’s original thesis on Coty...

Lululemon Athletica inc. (NASDAQ: LULU) got some love from one Wall Street analyst who said the company’s growth outlook is among the best in the entire retail industry. The Analyst Argus analyst John Staszak upgraded Lululemon from Hold to Buy and set a $150 price target for the stock. The...

Constellation Brands, Inc. Class A (NYSE: STZ) announced Wednesday an agreement to augment its stake in Canopy Growth Corp (NYSE: CGC) from 9.9 percent to 38 percent. The Analyst Reviewing the transaction, Bank of America Merrill Lynch analyst Bryan Spillane reiterated his Buy rating on...

Conn’s Inc (NASDAQ: CONN) has plenty of room for growth, according to a new initiation report. The Analyst Jefferies analyst Kyle Joseph initiated coverage on Conn's stock with a Buy rating and a $44 price target. The Thesis With Conn’s stock recovering from 2016 lows, Joseph said...

Cisco Systems, Inc. (NASDAQ: CSCO) stock traded higher by 3.9 percent Thursday after the company topped market expectations in the fourth quarter. Several Wall Street analysts weighed in on Cisco stock following the earnings report. Here’s a rundown of what they had to say. Under-The-Radar...

The U.S. dollar has firmed up in recent months amid geopolitical tensions and a divergence in monetary policy between the U.S. and the rest of the major global central banks, both of which have ratcheted up the appeal of safe havens such as the dollar. An unintended victim of the...

KeyBanc Capital Markets upgraded Multi-Color Corporation (NASDAQ: LABL) in February, but the research firm said a shift back to a bearish stance on the labelmaker is warranted. The Analyst Analyst Adam Josephson downgraded Multi-Color from Sector Weight to Underweight with a new $57 price...

AcelRx Pharmaceuticals Inc (NASDAQ: ACRX), with two product candidates in its pipeline, is a specialty pharma company focusing on pain management therapies. The Analyst Landenburg Thalmann analyst Michael Higgins initiated coverage of AcelRx with a Buy rating and $7 price target. The...

The best kind of analyst downgrade for investors is the one that comes because a stock has performed so well that it has exceeded expectations. On Thursday, AstraZeneca plc (ADR) (NYSE: AZN) was hit with just such a downgrade. The Analyst Jefferies analyst Ian Hilliker downgraded AstraZeneca from...